Teladoc stock kpis
Want to see TDOC full AI Analyst Report?
Visits
Teladoc reported visits of 4,000,000 in Q3 2026, down 2.4% from Q2 2026 and down 2.4% year over year. The highest value was 4,900,000 in Q1 2023.
Total telehealth visits completed on Teladoc’s platform, reflecting demand, platform utilization, and revenue-driving activity. Rising visit counts suggest stronger patient engagement and monetization potential; declines may signal competitive pressure or access issues.
Visits peaked in early‑2023 and have since settled into a lower, choppy range with recurring seasonal troughs; the decline tracks BetterHelp’s accelerated cash‑pay user losses and deliberate ad cuts. Management’s rollout of insurance and rising insurance sessions should eventually stabilize or re‑accelerate visits, but provider capacity constraints create a timing risk—near‑term visit counts may remain subdued while Teladoc converts demand and shifts mix toward higher‑margin Integrated Care and insurance revenue.
TDOC Visits
| Period | Visits |
|---|---|
| Q3 2026Sep 30, 2026 | 4,000,000 |
| Q2 2026Jun 30, 2026 | 4,100,000 |
| Q1 2026Mar 31, 2026 | 4,400,000 |
| Q4 2025Dec 31, 2025 | 4,300,000 |
| Q3 2025Sep 30, 2025 | 4,100,000 |
| Q2 2025Jun 30, 2025 | 4,100,000 |
| Q1 2025Mar 31, 2025 | 4,400,000 |
| Q4 2024Dec 31, 2024 | 4,400,000 |
| Q3 2024Sep 30, 2024 | 4,100,000 |
| Q2 2024Jun 30, 2024 | 4,700,000 |
| Q1 2024Mar 31, 2024 | 4,600,000 |
| Q4 2023Dec 31, 2023 | 4,400,000 |
| Q3 2023Sep 30, 2023 | 4,400,000 |
| Q2 2023Jun 30, 2023 | 4,700,000 |
| Q1 2023Mar 31, 2023 | 4,900,000 |
| Q4 2022Dec 31, 2022 | 4,800,000 |
| Q3 2022Sep 30, 2022 | 4,573,000 |
| Q2 2022Jun 30, 2022 | 4,659,000 |
| Q1 2022Mar 31, 2022 | 4,510,000 |
| Q4 2021Dec 31, 2021 | 4,407,000 |
| Q3 2021Sep 30, 2021 | 3,998,000 |
| Q2 2021Jun 30, 2021 | 3,652,000 |
| Q1 2021Mar 31, 2021 | 3,342,000 |
| Q4 2020Dec 31, 2020 | 3,117,000 |
| Q3 2020Sep 30, 2020 | 2,835,000 |
| Q2 2020Jun 30, 2020 | 2,755,000 |
| Q1 2020Mar 31, 2020 | 2,045,000 |
| Q4 2019Dec 31, 2019 | 1,239,000 |
| Q3 2019Sep 30, 2019 | 928,000 |
| Q2 2019Jun 30, 2019 | 908,000 |
| Q1 2019Mar 31, 2019 | 1,063,000 |
| Q4 2018Dec 31, 2018 | 861,000 |
| Q3 2018Sep 30, 2018 | 641,000 |
| Q2 2018Jun 30, 2018 | 533,000 |
| Q1 2018Mar 31, 2018 | 606,000 |
| Q4 2017Dec 31, 2017 | 463,000 |
| Q3 2017Sep 30, 2017 | 305,000 |
| Q2 2017Jun 30, 2017 | 310,000 |
| Q1 2017Mar 31, 2017 | 386,000 |

